We have complimented the Global Fund in the past on efforts at transparency. Two new offerings provide further examples of these efforts.

First, the Global Fund has instituted a "Price Reporting Mechanism" in which grant recipients post purchase prices of various products (including drug purchase prices). The Aidspan site offers a nice summary of this new offering. We're not aware of other donor agencies providing this sort of data.

Second, Aidspan reports that the Global Fund will be launching an "early warning system" describing grants that are unlikely to be renewed without corrective action. The hope is that publicizing difficulties will provide motivation to correct problems. Again, we're not aware of any other donor agency providing this sort of information (the more common approach is to hide problem grants).